Background T1a renal cell carcinoma (RCC) is typically considered a curable disease,
irrespective of the choice of local treatment modality. Objective To identify factors associated …

Objective Patients with clinical T1 renal cell carcinoma (cT1RCC) have risks for recurrence
and reduced overall survival despite being in the best prognostic group. This study aimed to …

Objectives We reviewed our patients with pathologic T3b renal cell carcinoma (RCC) to
determine which factors influenced survival in this high risk patient group. Methods From …

Methods We studied 5670 patients in Ontario, Canada undergoing PN or RN for T1a RCC.
The primary outcome was overall survival (OS). Secondary outcomes were cancer-specific …

Objective Identifying the predictive factors for tumor recurrence after partial nephrectomy
(PN) is useful to determine patients who require careful observation after surgery. Therefore …

Purpose Clinical staging is vital for treatment decision-making by renal cell carcinoma
(RCC) patients. Some RCCs clinically appear T1 on CT, but are actually T3a due to …

Purpose To evaluate the prognosis of pT3a upstaging from cT1 renal cell carcinoma, and to
compare the outcomes of partial or radical nephrectomy in cases of pT3a upstaging …

Objective To determine the oncological impact of pathological upstaging among patients
with clinical T1 (cT1) disease treated by partial nephrectomy or radical nephrectomy …

Objectives To compare the recurrence‐free survival of partial nephrectomy and radical
nephrectomy in patients with non‐metastatic pathological T3a renal cell carcinoma. Methods …

Background Large-scale analyses addressing cancer-specific mortality (CSM) in T1a renal
cell carcinoma (RCC) patients treated with local tumor destruction (LTD), relative to partial …